Fondazione Irccs Istituto Nazionale Dei Tumori, Milano
Clinical trials sponsored by Fondazione Irccs Istituto Nazionale Dei Tumori, Milano, explained in plain language.
-
Breathalyzer for breast cancer: a new hope for Non-Invasive detection?
Diagnosis OngoingThis study explores whether a breath test can identify breast cancer. Researchers will analyze the breath of 1000 women (half with breast cancer, half healthy) using a high-tech mass spectrometer. The goal is to see if cancer produces a unique chemical signature in the breath, po…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Diagnosis
Last updated May 26, 2026 04:35 UTC
-
New study tests Four-Pronged attack to stop lung cancer in smokers
Prevention OngoingThis study tests whether a program combining low-dose aspirin, help quitting smoking, diet changes, and more physical activity can reduce inflammation and prevent lung cancer in long-term smokers aged 55 to 75. About 2,000 participants will also get yearly low-dose CT scans for e…
Phase: PHASE2 • Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Prevention
Last updated May 20, 2026 12:01 UTC
-
Massive italian study aims to unlock secrets of rare colon cancer syndrome
Knowledge-focused OngoingThis study is a national registry in Italy that collects health information from 1,500 people with familial adenomatous polyposis (FAP) and related conditions. The goal is to better understand how these diseases progress, how they are currently managed, and how to improve care. N…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated May 26, 2026 05:30 UTC
-
AI and blood tests could make lung cancer screening smarter
Knowledge-focused OngoingThis study looks at whether combining artificial intelligence with blood tests and CT scans can better predict lung cancer risk in heavy smokers. Researchers will analyze data from 650 current or former heavy smokers to see if these tools can tell which lung nodules are likely to…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated May 26, 2026 05:25 UTC
-
New study aims to match kidney cancer patients to best therapy using advanced testing
Knowledge-focused OngoingThis study looks at 100 people with advanced kidney cancer to find better ways to choose the right first treatment. Researchers will analyze blood, tumor samples, and CT scans to identify patterns that predict which patients will respond well to therapy. The goal is to develop a …
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated May 26, 2026 04:36 UTC